Family lung disease study aims to uncover hidden risks

NCT ID NCT03437486

Recruiting now Knowledge-focused Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 750 healthy family members of people with familial pulmonary fibrosis, a lung scarring disease that runs in families. Researchers will track participants with yearly questionnaires and in-person visits every two years to see who develops the disease and why. The goal is to better understand the natural history of the condition and identify risk factors for future disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify early warning signs or risk factors for familial pulmonary fibrosis, potentially leading to earlier detection or prevention strategies.
What could go wrong: This is an observational study, not a treatment trial. It may take many years to see results, and findings may not apply to everyone with the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL INTERSTITIAL PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis inherited interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FAMILIAL INTERSTITIAL PNEUMONIA FAMILIAL PULMONARY FIBROSIS IDIOPATHIC PULMONARY FIBROSIS

Contacts and locations

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.